Clinical Trial Update: Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 mechanistic study evaluating nicotinamide riboside in humans with heart failure; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: University of Washington | Conditions: Heart Failure, Systolic, Heart Failure NYHA Class IV | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING